BioArctic - Stock

BioArctic ROCE 2024

BioArctic ROCE

0.25

Ticker

BIOA B.ST

ISIN

SE0010323311

WKN

A2H5GS

In 2024, BioArctic's return on capital employed (ROCE) was 0.25, a -2,604.02% increase from the -0.01 ROCE in the previous year.

BioArctic Aktienanalyse

What does BioArctic do?

BioArctic AB is a Swedish biotechnology company founded in 2003. The company is based in Stockholm and focuses on the development of innovative therapeutics for nervous system diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. The company uses its expertise in biological and chemical drug research to discover and develop new therapeutic possibilities, with a focus on Amyloid-Beta production. BioArctic's business strategy is based on partnerships with pharmaceutical and biotech companies worldwide, working closely with partners to develop therapies and products that meet the needs and expectations of patients and doctors. BioArctic conducts research in three different areas: Alzheimer's, Parkinson's, and spinal cord injuries. The company works with partners such as Nutricia, Eisai, Just Biotherapeutics, Abcam, Neuropharm, AbbVie, Q-Med, Uppsala University, and the Karolinska Institute to develop treatments for these conditions. BioArctic has already brought several promising products to market, including BAN2401 for Alzheimer's and SC0806 for spinal cord injuries. Overall, BioArctic is a leading company in biological and chemical drug research, with a focus on developing new therapies and products for the benefit of patients and doctors worldwide. BioArctic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling BioArctic's Return on Capital Employed (ROCE)

BioArctic's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing BioArctic's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

BioArctic's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in BioArctic’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about BioArctic stock

What is the ROCE (Return on Capital Employed) of BioArctic this year?

The ROCE of BioArctic is 0.25 undefined this year.

How has the ROCE (Return on Capital Employed) of BioArctic developed compared to the previous year?

The ROCE of BioArctic has increased by -2,604.02% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of BioArctic?

A high Return on Capital Employed (ROCE) indicates that BioArctic has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of BioArctic?

A low ROCE (Return on Capital Employed) can indicate that BioArctic has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from BioArctic impact the company?

An increase in the ROCE of BioArctic can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of BioArctic affect the company?

A decrease in ROCE of BioArctic can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of BioArctic?

Some factors that can affect BioArctic's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of BioArctic so important for investors?

The ROCE of BioArctic is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can BioArctic take to improve the ROCE?

To improve the ROCE, BioArctic can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does BioArctic pay?

Over the past 12 months, BioArctic paid a dividend of 1.5 SEK . This corresponds to a dividend yield of about 0.68 %. For the coming 12 months, BioArctic is expected to pay a dividend of 0 SEK.

What is the dividend yield of BioArctic?

The current dividend yield of BioArctic is 0.68 %.

When does BioArctic pay dividends?

BioArctic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioArctic?

BioArctic paid dividends every year for the past 5 years.

What is the dividend of BioArctic?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioArctic located?

BioArctic is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioArctic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioArctic from 5/16/2019 amounting to 1.5 SEK, you needed to have the stock in your portfolio before the ex-date on 5/10/2019.

When did BioArctic pay the last dividend?

The last dividend was paid out on 5/16/2019.

What was the dividend of BioArctic in the year 2023?

In the year 2023, BioArctic distributed 0 SEK as dividends.

In which currency does BioArctic pay out the dividend?

The dividends of BioArctic are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BioArctic

Our stock analysis for BioArctic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioArctic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.